Price target
8.34RUSD+7.22+644.34%
The 4 analysts offering 1 year price forecasts for Cardiol Therapeutics Inc. have a max estimate of 9.90 and a min estimate of 6.88.
Analyst rating
Based on 4 analysts giving stock ratings to Cardiol Therapeutics Inc. in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
4
Buy
0
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
−0.14
−0.11
−0.07
−0.04
0.00
Reported
Estimate
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Reported
−0.08
−0.09
−0.07
−0.09
−0.10
−0.07
−0.13
—
—
—
—
Estimate
−0.08
−0.09
−0.09
−0.09
−0.09
−0.10
−0.09
−0.09
−0.09
−0.09
−0.09
Surprise
0.00%
+4.00%
+25.00%
0.00%
−16.98%
+29.30%
−41.25%
—
—
—
—
Revenue
Forecast
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
0.00
Reported
Estimate
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Reported
0.00
0.00
0.00
0.00
0.00
0.00
0.00
—
—
—
—
Estimate
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Surprise
—
—
—
—
—
—
—
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CRDL EPS for the last quarter is −0.13 USD despite the estimation of −0.09 USD. In the next quarter EPS is expected to reach −0.09 USD. Track more of Cardiol Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Cardiol Therapeutics Inc. revenue is expected to reach 0.00 USD. Check out Cardiol Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, CRDL price target is 8.58 USD with a max estimate of 9.95 USD and a min estimate of 6.91 USD. Check if this forecast comes true in a year, meanwhile watch Cardiol Therapeutics Inc. stock price chart and keep track of the current situation with CRDL news and stock market news.